These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

761 related items for PubMed ID: 25499305

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR, Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E, Reddy B, Botti C, Jaff MR.
    Catheter Cardiovasc Interv; 2012 Nov 01; 80(5):852-9. PubMed ID: 22422738
    [Abstract] [Full Text] [Related]

  • 3. Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study.
    Schmidt A, Zeller T, Sievert H, Krankenberg H, Torsello G, Stark MA, Scheinert D.
    J Endovasc Ther; 2014 Feb 01; 21(1):52-60. PubMed ID: 24502484
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans.
    Su Z, Li Y, Yang S, Guo J, Guo L, Gu Y.
    Ann R Coll Surg Engl; 2022 Nov 01; 104(9):667-672. PubMed ID: 35446161
    [Abstract] [Full Text] [Related]

  • 9. Differences in patient selection and outcomes between SilverHawk atherectomy and laser ablation in the treatment of femoropopliteal in-stent restenosis: a retrospective analysis from a single center.
    Shammas NW, Shammas GA, Jerin M.
    J Endovasc Ther; 2013 Dec 01; 20(6):844-52. PubMed ID: 24325703
    [Abstract] [Full Text] [Related]

  • 10. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ.
    Cardiovasc Revasc Med; 2020 Jun 01; 21(6):771-778. PubMed ID: 31761634
    [Abstract] [Full Text] [Related]

  • 11. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
    Yu C, Tang W, Ren T, Chen Q, Lu R, Gao Y.
    J Endovasc Ther; 2024 Jun 01; 31(3):390-399. PubMed ID: 36189843
    [Abstract] [Full Text] [Related]

  • 12. Randomized controlled trial of orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for treatment of femoropopliteal artery in-stent restenosis.
    Liao CJ, Song SH, Li T, Zhang Y, Zhang WD.
    Int Angiol; 2019 Oct 01; 38(5):365-371. PubMed ID: 31566320
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Five-Year Freedom From Target-Lesion Revascularization Using Excimer Laser Ablation Therapy in the Treatment of In-Stent Restenosis of Femoropopliteal Arteries.
    Shammas NW, Shammas GA, Arikat L, Shammas AN, Darrow A, Banerjee A, Rudy B.
    J Invasive Cardiol; 2017 Jun 01; 29(6):207-208. PubMed ID: 28570235
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW, Shammas GA, Jones-Miller S, Shammas WJ, Bou-Dargham B, Shammas AN, Banerjee S, Rachwan RJ, Daher GE.
    Cardiovasc Revasc Med; 2018 Oct 01; 19(7 Pt A):771-777. PubMed ID: 30420096
    [Abstract] [Full Text] [Related]

  • 17. JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study.
    Shammas NW, Shammas GA, Banerjee S, Popma JJ, Mohammad A, Jerin M.
    J Endovasc Ther; 2016 Apr 01; 23(2):339-46. PubMed ID: 26921281
    [Abstract] [Full Text] [Related]

  • 18. Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.
    Bosiers M, Deloose K, Callaert J, Verbist J, Hendriks J, Lauwers P, Schroë H, Lansink W, Scheinert D, Schmidt A, Zeller T, Beschorner U, Noory E, Torsello G, Austermann M, Wauters J.
    J Cardiovasc Surg (Torino); 2020 Oct 01; 61(5):617-625. PubMed ID: 33231029
    [Abstract] [Full Text] [Related]

  • 19. Initial Results of Standard Balloon Angioplasty Versus Drug Coated Balloon Alone Versus in Association With Laser Excimer Atherectomy in the Treatment of Femoropopliteal Artery In Stent Restenosis (INTACT).
    Ducasse E, Sapoval M, Brunet J, Goueffic Y, Lermusiaux P, Caradu C.
    Eur J Vasc Endovasc Surg; 2024 May 01; 67(5):850-851. PubMed ID: 38301872
    [No Abstract] [Full Text] [Related]

  • 20. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y, Soga Y, Iida O, Shiraki T, Kobayashi Y, Hiramori S, Ando K.
    J Endovasc Ther; 2016 Jun 01; 23(3):461-7. PubMed ID: 27004496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.